JPM24, Day 2: Cigna execs reaffirm partnership-focused growth strategy fiercehealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercehealthcare.com Daily Mail and Mail on Sunday newspapers.
Lawmakers are concerned the state insurance plan’s pharmacy benefit manager may be shortchanging smaller independently owned pharmacies with reimbursement rates that favor large corporations.
CVS Health CostVantage drug pricing model announced modernhealthcare.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernhealthcare.com Daily Mail and Mail on Sunday newspapers.
The Global Insulin Biosimilars Industry is on a trajectory of remarkable growth, with a projected worth of US$ 1,507.7 million in 2023 set to surge to over US$ 2,096.5 million by 2033. This surge is fueled by a robust adoption rate, with insulin biosimilars, alongside other insulin pharmaceutical products, anticipat.
Several employees of drug middleman Express Scripts last year raked in bonuses of $750,000 each for getting the business of a managed-care company that depends on Medicaid for the bulk of its business.